DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Lonial S, Weiss BM, Usmani SZ, Singhal S, Chari A, Bahlis NJ. et al.
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): An open-label, randomised, phase 2 trial.
Lancet 2016;
387: 1551-60
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.